| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/CCO.0B013E3280148A2F |
| P698 | PubMed publication ID | 17272988 |
| P2093 | author name string | James N George | |
| Kiarash Kojouri | |||
| P433 | issue | 2 | |
| P304 | page(s) | 148-154 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Current Opinion in Oncology | Q1909046 |
| P1476 | title | Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation | |
| P478 | volume | 19 |
| Q26992169 | A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury |
| Q33398895 | Attending rounds: microangiopathic hemolytic anemia with renal insufficiency |
| Q80525543 | Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
| Q50622232 | Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy. |
| Q33386036 | Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning |
| Q42115220 | Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation |
| Q35881360 | Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study |
| Q33392923 | Late-onset intestinal perforation in the setting of posttransplantation microangiopathy: a case report |
| Q33396969 | Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
| Q33413498 | Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus |
| Q33378414 | The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection |
| Q33424153 | The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy |
| Q33383033 | The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). |
| Q33394558 | Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center |
| Q49988912 | Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy. |
| Q99604299 | Thrombotic Microangiopathy After Post-Transplantation Cyclophosphamide-Based GVHD Prophylaxis |
| Q33393404 | Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis |
| Q33426602 | Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation. |
| Q30251535 | Venous thromboembolism following hematopoietic stem cell transplantation-a systematic review and meta-analysis |
Search more.